- Home
- TXG vs ARR Comparison
TXG vs ARR Comparison
Compare TXG & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- ARR
- Stock Information
- Founded
- TXG 2012
- ARR 2008
- Country
- TXG United States
- ARR United States
- Employees
- TXG N/A
- ARR N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- ARR Real Estate Investment Trusts
- Sector
- TXG Industrials
- ARR Real Estate
- Exchange
- TXG Nasdaq
- ARR Nasdaq
- Market Cap
- TXG 1.3B
- ARR 1.4B
- IPO Year
- TXG 2019
- ARR N/A
- Fundamental
- Price
- TXG $14.11
- ARR $16.84
- Analyst Decision
- TXG Buy
- ARR Hold
- Analyst Count
- TXG 12
- ARR 6
- Target Price
- TXG $14.13
- ARR $18.50
- AVG Volume (30 Days)
- TXG 3.7M
- ARR 2.9M
- Earning Date
- TXG 08-07-2025
- ARR 07-23-2025
- Dividend Yield
- TXG N/A
- ARR 17.10%
- EPS Growth
- TXG N/A
- ARR N/A
- EPS
- TXG N/A
- ARR N/A
- Revenue
- TXG $624,662,000.00
- ARR $20,589,000.00
- Revenue This Year
- TXG N/A
- ARR $450.49
- Revenue Next Year
- TXG $5.69
- ARR $19.01
- P/E Ratio
- TXG N/A
- ARR N/A
- Revenue Growth
- TXG N/A
- ARR N/A
- 52 Week Low
- TXG $6.78
- ARR $13.18
- 52 Week High
- TXG $24.76
- ARR $21.08
- Technical
- Relative Strength Index (RSI)
- TXG 68.91
- ARR 55.06
- Support Level
- TXG $11.45
- ARR $16.35
- Resistance Level
- TXG $14.16
- ARR $16.89
- Average True Range (ATR)
- TXG 0.71
- ARR 0.27
- MACD
- TXG 0.08
- ARR 0.00
- Stochastic Oscillator
- TXG 93.01
- ARR 80.56
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.